Table 1.
Characteristics of the studied population at inclusion in the cohort.
| No liver disease n = 28 | Any liver disease n = 83 | p * | |
|---|---|---|---|
| Male | 15 (53.6) | 71 (85.5) | <0.01 |
| Age (years) | 55.4 [51; 64.8] | 65.3 [61.1; 70.9] | <0.01 |
| BMI (kg/m²) | 22.2 [19.8; 23.6] | 26.5 [23.6; 28.7] | <0.01 |
| Smoking (pack year) | 32.5 [9.6; 40.3] | 41 [22; 50] | 0.11 |
| OSA | 0.03 | ||
| Untreated | 4 (14.8) | 33 (40.7) | |
| Treated | 2 (7.4) | 8 (9.9) | |
| No | 21 (77.8) | 40 (49.4) | |
| Hypertension | 9 (32.1) | 44 (53) | 0.06 |
| Dyslipidemia | 6 (21.4) | 39 (47) | 0.02 |
| Type 2 diabetes | 1 (3.6) | 16 (19.3) | 0.05 |
| HOMA | 1.6 [0.8; 3.2] | 2.1 [1; 5.1] | 0.22 |
| FEV1 (%) | 67.5 [53.5; 88.5] | 64 [53; 76] | 0.19 |
| FEV1/FVC (%) | 53.5 [44.5; 67.5] | 57 [49; 65] | 0.94 |
| GOLD | 0.07 | ||
| 1 | 8 (28.6) | 9 (10.8) | |
| 2 | 13 (46.4) | 53 (63.9) | |
| 3–4 | 7 (25) | 21 (25.3) |
BMI, body mass index; FEV1, Forced Expiratory Volume in one second; FVC, Forced Vital Capacity; HOMA, Homeostasis model assessment of insulin resistance; OSA, obstructive sleep apnea.
Data are expressed as n (%) or median and IQR. Comparison of the variables was performed using a Mann-Whitney test for quantitative variables and a Chi square test or an exact Fisher test for qualitative variables.
*Data from patients with no liver disease compared to those with any liver disease.